Location: United States
The FDA-cleared program is delivered through a mobile app over 6-9 weeks.
Around 10% of American adults have chronic insomnia, which is defined as sleeplessness that occurs at least three times a week over three months. Sleep is vital for a person’s health, and long-term sleep deprivation can cause a range of complications: fatigue, mood swings, irritability, slowed reaction times, weight gain, mental illness, and many more.
Somryst by Pear Therapeutics is an approved digital therapeutics tool for chronic insomnia available on prescription. It is a 6-9 week course delivered through a mobile or tablet app that uses cognitive behavioural therapy (CBT) to help people living with chronic insomnia get the sleep they need.
For a potential patient, the process starts with a 10-minute consultation either through messaging or video with a healthcare professional. If the professional feels the patient is a good candidate for Somryst, they will receive a prescription which allows them to purchase the program and download the app to begin.
Over the 6-9 weeks, the user will work through six lessons to help them better understand and control their chronic insomnia. It seeks to address the core issues affecting sleep. By understanding thoughts, behaviours and lifestyle; a user can then use new strategies to develop new sleeping patterns. They will work through additional exercises for a few minutes each day to work towards a more productive sleep window.
Website: https://www.somryst.com/
Email: info@peartherapeutics.com
Image: Somryst
